1. Service Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global AI in Drug
Discovery Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component Type (Software and Services)
5.2.2. By Drug Type (Small Molecule and Large
Molecule)
5.2.3. By Application Type (Preclinical Testing, Drug
Optimization, and Repurposing, Target Identification, Candidate Screening, and
Others)
5.2.4. By Therapeutic Area (Oncology,
Neurodegenerative Diseases, Cardiovascular Diseases, Rare Diseases, and Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Market Map
6.
North America AI in
Drug Discovery Market Outlook
6.1.
Market Size &
Forecast
6.1.1. By Value
6.2.
Market Share &
Forecast
6.2.1.
By Component Type
6.2.2. By Drug Type
6.2.3.
By Application Type
6.2.4.
By Therapeutic Area
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States AI in Drug Discovery
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Component Type
6.3.1.2.2.
By Drug Type
6.3.1.2.3.
By Application Type
6.3.1.2.4.
By Therapeutic Area
6.3.2. Canada AI in Drug Discovery
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Component Type
6.3.2.2.2.
By Drug Type
6.3.2.2.3.
By Application Type
6.3.2.2.4.
By Therapeutic Area
6.3.3. Mexico AI in Drug Discovery
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Component Type
6.3.3.2.2.
By Drug Type
6.3.3.2.3.
By Application Type
6.3.3.2.4.
By Therapeutic Area
7.
Europe AI in Drug
Discovery Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component Type
7.2.2. By Drug Type
7.2.3. By Application Type
7.2.4. By Therapeutic Area
7.3. Europe: Country Analysis
7.3.1. Germany AI in Drug Discovery
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Component Type
7.3.1.2.2.
By Drug Type
7.3.1.2.3.
By Application Type
7.3.1.2.4.
By Therapeutic Area
7.3.2. United Kingdom AI in Drug Discovery
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Component Type
7.3.2.2.2.
By Drug Type
7.3.2.2.3.
By Application Type
7.3.2.2.4.
By Therapeutic Area
7.3.3. Italy AI in Drug Discovery Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By Component Type
7.3.3.2.2.
By Drug Type
7.3.3.2.3.
By Application Type
7.3.3.2.4.
By Therapeutic Area
7.3.4. France AI in Drug Discovery
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Component Type
7.3.4.2.2.
By Drug Type
7.3.4.2.3.
By Application Type
7.3.4.2.4.
By Therapeutic Area
7.3.5. Spain AI in Drug Discovery Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Component Type
7.3.5.2.2.
By Drug Type
7.3.5.2.3.
By Application Type
7.3.5.2.4.
By Therapeutic Area
8.
Asia-Pacific AI in
Drug Discovery Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component Type
8.2.2. By Drug Type
8.2.3. By Application Type
8.2.4. By Therapeutic Area
8.3. Asia-Pacific: Country Analysis
8.3.1. China AI in Drug Discovery Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Component Type
8.3.1.2.2.
By Drug Type
8.3.1.2.3.
By Application Type
8.3.1.2.4.
By Therapeutic Area
8.3.2. India AI in Drug Discovery Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Component Type
8.3.2.2.2.
By Drug Type
8.3.2.2.3.
By Application Type
8.3.2.2.4.
By Therapeutic Area
8.3.3. Japan AI in Drug Discovery Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Component Type
8.3.3.2.2.
By Drug Type
8.3.3.2.3.
By Application Type
8.3.3.2.4.
By Therapeutic Area
8.3.4. South Korea AI in Drug Discovery
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Component Type
8.3.4.2.2.
By Drug Type
8.3.4.2.3.
By Application Type
8.3.4.2.4.
By Therapeutic Area
8.3.5. Australia AI in Drug Discovery
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Component Type
8.3.5.2.2.
By Drug Type
8.3.5.2.3.
By Application Type
8.3.5.2.4.
By Therapeutic Area
9.
South America AI in
Drug Discovery Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component Type
9.2.2. By Drug Type
9.2.3. By Application Type
9.2.4. By Therapeutic Area
9.3. South America: Country Analysis
9.3.1. Brazil AI in Drug Discovery
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Component Type
9.3.1.2.2.
By Drug Type
9.3.1.2.3.
By Application Type
9.3.1.2.4.
By Therapeutic Area
9.3.2. Argentina AI in Drug Discovery
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Component Type
9.3.2.2.2.
By Drug Type
9.3.2.2.3.
By Application Type
9.3.2.2.4.
By Therapeutic Area
9.3.3. Colombia AI in Drug Discovery
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Component Type
9.3.3.2.2.
By Drug Type
9.3.3.2.3.
By Application Type
9.3.3.2.4.
By Therapeutic Area
10.
Middle East and
Africa AI in Drug Discovery Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Component Type
10.2.2. By Drug Type
10.2.3. By Application Type
10.2.4. By Therapeutic Area
10.3.
MEA: Country
Analysis
10.3.1. South Africa AI in Drug Discovery
Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Component Type
10.3.1.2.2.
By Drug Type
10.3.1.2.3.
By Application Type
10.3.1.2.4.
By Therapeutic Area
10.3.2. Saudi Arabia AI in Drug Discovery
Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Component Type
10.3.2.2.2.
By Drug Type
10.3.2.2.3.
By Application Type
10.3.2.2.4.
By Therapeutic Area
10.3.3. UAE AI in Drug Discovery Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Component Type
10.3.3.2.2.
By Drug Type
10.3.3.2.3.
By Application Type
10.3.3.2.4.
By Therapeutic Area
11. Market Dynamics
12. Market Trends & Developments
13.
Global AI in Drug Discovery Market: SWOT Analysis
14. Competitive Landscape
14.1.
Business Overview
14.2.
Services Offerings
14.3.
Recent Developments
14.4.
Key Personnel
14.5.
SWOT Analysis
14.5.1. GNS Healthcare
14.5.2. BioSymetrics
14.5.3. BPGbio, Inc.
14.5.4. Atomwise Inc.
14.5.5. Owkin Inc.
14.5.6. NVIDIA Corporation
14.5.7. IBM Corporation
14.5.8. Microsoft Corporation
14.5.9. Aria Pharmaceuticals, Inc.
14.5.10.
Insilico Medicine Inc.
15.
Strategic Recommendations
About Us & Disclaimer